Lack of decorin expression by human bladder cancer cells offers new tools in the therapy of urothelial malignancies
about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansOncosuppressive functions of decorinDecorin: A Growth Factor Antagonist for Tumor Growth InhibitionDecorin differentially modulates the activity of insulin receptor isoform A ligands.Recombinant fibromodulin and decorin effects on NF-κB and TGFβ1 in the 4T1 breast cancer cell line.The interplay of extracellular matrix and microbiome in urothelial bladder cancer.Decorin as a multivalent therapeutic agent against cancer.Decorin in Human Colon Cancer: Localization In Vivo and Effect on Cancer Cell Behavior In Vitro.Reduced decorin expression in the tumor stroma correlates with tumor proliferation and predicts poor prognosis in patients with I-IIIA non-small cell lung cancer.Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?Human Metaplastic Breast Carcinoma and Decorin.Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment.Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic marker in urothelial carcinoma of bladder.Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells.
P2860
Q21710680-5EA8E36E-3A2A-473E-8278-C4AC818E02C4Q26745697-305ACBCB-7C9F-4D67-8E03-BE31F6F13A64Q26772197-A27D0DB5-C43E-4818-9AAC-741F34D617B5Q33690540-9A565A68-F13D-4313-B5FE-456B94241DBBQ33750977-5F44391C-DA2B-4693-988D-61483BA5AB12Q35868405-0DBE8BFF-D898-407D-B6EE-35D8444AAD9EQ36578803-1793744D-1F65-43C6-A5F0-983DB6C41FD7Q38871847-82307E69-7A90-4778-A0C3-5061C0EC7F03Q39303746-6336044A-F105-4829-890A-E6E34E485396Q47281580-BFDFBC32-E479-4FA7-BAE0-F6AE29F8D71EQ48219599-173F2B72-4DF1-49EB-9E20-81AFBB4FC1E9Q50052813-7B3C9B2C-C0CF-4B3D-A88A-1AA11492FA31Q51026475-406DCE36-9D0E-45E4-A5BC-CA89AEBE22ABQ52597557-B36A70A1-D1F4-4F81-B91F-DB00C421722B
P2860
Lack of decorin expression by human bladder cancer cells offers new tools in the therapy of urothelial malignancies
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Lack of decorin expression by ...... apy of urothelial malignancies
@ast
Lack of decorin expression by ...... apy of urothelial malignancies
@en
type
label
Lack of decorin expression by ...... apy of urothelial malignancies
@ast
Lack of decorin expression by ...... apy of urothelial malignancies
@en
prefLabel
Lack of decorin expression by ...... apy of urothelial malignancies
@ast
Lack of decorin expression by ...... apy of urothelial malignancies
@en
P2093
P2860
P1433
P1476
Lack of decorin expression by ...... apy of urothelial malignancies
@en
P2093
Hannu Järveläinen
Marie Nyman
Matti Laato
Peter J Boström
Pia Boström
Sanna Vuorikoski
P2860
P304
P356
10.1371/JOURNAL.PONE.0076190
P407
P577
2013-10-11T00:00:00Z